Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer by Yuanfa Feng, Yuanfa Feng, Yulin Deng, Zhenfeng Tang, Shanghua Cai, Shanghua Cai, Jinchuang Li, Ren Liu, Jiaming Wan, Huichan He, Guohua Zeng, Jianheng Ye, Zhaodong Han, Weide Zhong, Weide Zhong, Weide Zhong, Weide Zhong, Weide Zhong

Get full text

A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma by Hongxiang Liu, Hongxiang Liu, Yong Luo, Shankun Zhao, Jing Tan, Minjian Chen, Xihai Liu, Jianheng Ye, Shanghua Cai, Shanghua Cai, Yulin Deng, Jinchuang Li, Huichan He, Xin Zhang, Weide Zhong, Weide Zhong, Weide Zhong, Weide Zhong, Weide Zhong

Get full text

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer by Jianheng Ye, Shanghua Cai, Yuanfa Feng, Jinchuang Li, Zhiduan Cai, Yulin Deng, Ren Liu, Xuejin Zhu, Jianming Lu, Yangjia Zhuo, Yingke Liang, Jianjiang Xie, Yanqiong Zhang, Huichan He, Zhaodong Han, Zhenyu Jia, Weide Zhong

Get full text

FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation by Ren Liu, Zhihao Zou, Lingwu Chen, Yuanfa Feng, Jianheng Ye, Yulin Deng, Xuejin Zhu, Yixun Zhang, Jundong Lin, Shanghua Cai, Zhenfeng Tang, Yingke Liang, Jianming Lu, Yangjia Zhuo, Zhaodong Han, Xiaohui Ling, Yuxiang Liang, Zongren Wang, Weide Zhong

Get full text